Investors Research Corp’s Kaleido Biosciences, Inc. Common Stock KLDO Stock Holding History

Investors Research Corp’s Portfolio KLDO Stock Details KLDO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-100	Closed	–	–	1204
2022 Q1	$0	Hold	100	–	–	﹤0.01%	1136
2021 Q4	$0	Hold	100	–	–	﹤0.01%	1088
2021 Q3	$1K	Hold	100	–	–	﹤0.01%	985
2021 Q2	$1K	Sell	100 -30	-23%	-$213	﹤0.01%	968
2021 Q1	$1K	Sell	130 -25	-16%	-$272	﹤0.01%	963
2020 Q4	$1K	Hold	155	–	–	﹤0.01%	1064
2020 Q3	$2K	Buy	+155	New	+$1.07K	﹤0.01%	1018

Other funds holding KLDO

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Investors Research Corp's KLDO Position: Q2 2022 in Review

Investors Research Corp sold out of Kaleido Biosciences, Inc. Common Stock (KLDO) in Q2 2022, closing a stake of 100 shares.

Investors Research Corp first reported a position in KLDO in Q3 2020 and held it in 7 quarters. The position peaked at $2K in Q3 2020. 3 funds tracked by Wall St. Rank hold KLDO as of Q2 2022.

Investors Research Corp reported no remaining Kaleido Biosciences, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
Investors Research Corp sold 100 Kaleido Biosciences, Inc. Common Stock shares in Q2 2022.
Investors Research Corp first reported a position in Kaleido Biosciences, Inc. Common Stock in Q3 2020 and held it in 7 quarters.
Investors Research Corp's Kaleido Biosciences, Inc. Common Stock position peaked at $2K in Q3 2020.
3 funds tracked by Wall St. Rank held Kaleido Biosciences, Inc. Common Stock as of Q2 2022.

Based on Investors Research Corp's 13F filing for Q2 2022, filed 21 Jul 2022.